Back

Predicting the efficacy of Recombinant Human Thrombopoietin in Treating Cancer Therapy-Related Thrombocytopenia:based on stacking ensemble methods

2025-12-17 health informatics Title + abstract only
View on medRxiv
Show abstract

The project aimed to develop a data-driven approach for predicting platelet recovery in cancer treatment-induced thrombocytopenia (CTIT) patients receiving recombinant human thrombopoietin (Rh-TPO). By integrating key clinical indicators into a predictive modeling framework, the study sought to enhance understanding of individual treatment responses and facilitate timely clinical decision-making. A retrospective two-stage modeling analysis was conducted on 400 hospitalized CTIT patients who rece...

Predicted journal destinations